tiprankstipranks
Blurbs

Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Applied Therapeutics (APLT) and Align Tech (ALGN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mersana Therapeutics (MRSNResearch Report), Applied Therapeutics (APLTResearch Report) and Align Tech (ALGNResearch Report).

Mersana Therapeutics (MRSN)

In a report issued on September 6, Colleen M. Kusy from Robert W. Baird maintained a Hold rating on Mersana Therapeutics, with a price target of $1.00. The company’s shares closed last Thursday at $1.28, close to its 52-week low of $0.80.

According to TipRanks.com, Kusy has 0 stars on 0-5 stars ranking scale with an average return of -22.2% and a 23.8% success rate. Kusy covers the Healthcare sector, focusing on stocks such as EyePoint Pharmaceuticals, Iovance Biotherapeutics, and Apellis Pharmaceuticals.

The word on The Street in general, suggests a Hold analyst consensus rating for Mersana Therapeutics with a $1.33 average price target, which is a 9.0% upside from current levels. In a report issued on September 5, Truist Financial also maintained a Hold rating on the stock.

See the top stocks recommended by analysts >>

Applied Therapeutics (APLT)

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Applied Therapeutics on September 6 and set a price target of $14.00. The company’s shares closed last Thursday at $1.57.

According to TipRanks.com, Skorney is a 1-star analyst with an average return of -2.5% and a 45.1% success rate. Skorney covers the Healthcare sector, focusing on stocks such as Crinetics Pharmaceuticals, Eiger Biopharmaceuticals, and Vertex Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Applied Therapeutics with a $14.00 average price target.

Align Tech (ALGN)

In a report released yesterday, Jeff Johnson from Robert W. Baird reiterated a Buy rating on Align Tech, with a price target of $405.00. The company’s shares closed last Thursday at $340.93.

According to TipRanks.com, Johnson is a 5-star analyst with an average return of 16.8% and a 56.2% success rate. Johnson covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Tandem Diabetes Care, and Patterson Companies.

Align Tech has an analyst consensus of Moderate Buy, with a price target consensus of $402.78, which is a 9.5% upside from current levels. In a report issued on August 30, HSBC also initiated coverage with a Buy rating on the stock with a $450.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MRSN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles